Modifying CMV-Specific T Cells with a Novel Bicistronic CD4-CAR/MAC46 Vector to Target HIV
NM Johnson - 2020 - search.proquest.com
… Ultimately this impaired ability of HIV-1 specific CD8 T cells to … Cytomegalovirus vaccine
vectors were designed in the … maintain high frequency, effectordifferentiated, and broadly …
vectors were designed in the … maintain high frequency, effectordifferentiated, and broadly …
[HTML][HTML] T cell engaging immunotherapies, highlighting chimeric antigen receptor (CAR) T cell therapy
E De Bousser, N Callewaert, N Festjens - Cancers, 2021 - mdpi.com
… addressed for the broad use of CAR T cell therapy. These include … Vaccination of CAR T
cell-treated mice with activated DCs pulsed with WT1 peptide, enhanced CAR T cell expansion …
cell-treated mice with activated DCs pulsed with WT1 peptide, enhanced CAR T cell expansion …
[HTML][HTML] Conserved multiepitope vaccine constructs: A potent HIV-1 therapeutic vaccine in clinical trials
E Akbari, M Seyedinkhorasani… - Brazilian Journal of …, 2023 - SciELO Brasil
… It can induce effective HIV-1-specific immunity to control … regions containing a wide range of
critical T- and B-cell epitopes of … HIV-1-specific T cell responses. J Transl Med. 2011;9:1-20.- …
critical T- and B-cell epitopes of … HIV-1-specific T cell responses. J Transl Med. 2011;9:1-20.- …
[PDF][PDF] Curing HIV: seeking to target and clear persistent infection
… The frequency of HIV-1-specific CD8+ T cells remains stable over time in durably … Current
therapies can be broadly divided into traditional therapeutic vaccine approaches that seek to …
therapies can be broadly divided into traditional therapeutic vaccine approaches that seek to …
[图书][B] Defining Antiviral T Cell Responses Elicited by Vaccines versus Infection in HIV-1 and in SARS-CoV-2
EA Taus - 2022 - search.proquest.com
… methods to reliably generate T cell responses capable of broad recognition, and it … receptors,
or TCR. The … (53)) can become activated more easily and undergo clonal expansion much …
or TCR. The … (53)) can become activated more easily and undergo clonal expansion much …
Current status and future development of anti-HIV chimeric antigen receptor T-cell therapy
Y Mao, C Zhao, P Zheng, X Zhang, J Xu - Immunotherapy, 2021 - Future Medicine
… of uniform HIV-1-specific CAR T cells not recognized by HIV [… bNAb injection, CD21 decoy
receptor neutralization and use … the latent HIV reservoir with wide tissue distribution and make …
receptor neutralization and use … the latent HIV reservoir with wide tissue distribution and make …
Stem cell-like memory T cells: The generation and application
Y Wang, F Qiu, Y Xu, X Hou, Z Zhang… - Journal of Leukocyte …, 2021 - academic.oup.com
… -engineered T cells, TCR gene-modified T cells, and vaccines. … A genome-wide DNA
methylation assessment evaluated the … stimulated CD8 T cells favored the elicitation and …
methylation assessment evaluated the … stimulated CD8 T cells favored the elicitation and …
[HTML][HTML] Shocking HIV-1 with immunomodulatory latency reversing agents
A Kula-Pacurar, A Rodari, G Darcis, C Van Lint - Seminars in immunology, 2021 - Elsevier
… (by rapid expansion of virus specific CD8 + T cells), to reduce … immunotherapy and to optimize
efficiency of vaccines. … such as CD8 + T cells depletion or broadly neutralizing antibodies …
efficiency of vaccines. … such as CD8 + T cells depletion or broadly neutralizing antibodies …
Examining the sequence and function of HIV Gag-specific T cell receptors restricted by HLA-B* 57 and HLA-E
HSA Hsieh - 2023 - summit.sfu.ca
… suppresses HIV viremia, but no vaccine or cure exists. Rare … research and discuss the
broader implications of this thesis. … expansion of virus-specific CD8 T cells, resulting in a biased …
broader implications of this thesis. … expansion of virus-specific CD8 T cells, resulting in a biased …
Antiproliferative Therapeutics and Latency Reversal Strategies to Target the Latent HIV-1 Reservoir
EA Innis - 2023 - search.proquest.com
… agents that prevent proliferation of latently infected T cells … The wide acceptance and
accessibility of ART in 1995 … demonstrated enhanced innate and HIV-1-specific immunity in vivo …
accessibility of ART in 1995 … demonstrated enhanced innate and HIV-1-specific immunity in vivo …